Form 4: Sotera Health Director James Neary Receives RSU Grant

Director James Neary was granted 14,970 restricted stock units as part of the Sotera Health Company 2020 Omnibus Incentive Plan.

Summary

• Director James Neary acquired 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents a right to receive one share of common stock upon vesting.
• The RSUs vest on the earlier of the first anniversary of the grant or the day before the next annual shareholders meeting.
• Following this transaction, the director's total beneficial ownership is 95,751 shares, including the new RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard retention mechanism for non-employee directors.

Negatives

• None identified; this is a routine equity grant disclosure.

Risks

• Vesting is contingent upon the director's continued service to the company.

Future Outlook

The RSUs are expected to vest in full on the earlier of May 22, 2027, or the date immediately preceding the next annual shareholders meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices designed to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The grant structure follows standard equity compensation practices for publicly traded companies in the healthcare services sector.
• Vesting schedules tied to annual meetings are consistent with typical board compensation policies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 14,970 RSUs on the earlier of the first anniversary or the next annual meeting.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units